Data sourced from ClinicalTrials.gov (NIH registry) Updated weekly IRB-supervised studies only

Home/SD/Sioux Falls

Updated August 2026 from ClinicalTrials.gov

Paid Clinical Trials in Sioux Falls, SD

Q: Do I need to be sick to join a clinical trial in Sioux Falls?

No. Many studies recruit healthy volunteers, especially early-phase studies run at dedicated research centers. Others need participants diagnosed with a specific condition. Every trial lists its eligibility criteria — age range, condition, medications — and the study team screens you before enrollment.

Q: Are clinical trials in Sioux Falls safe?

Every trial on this page is registered on ClinicalTrials.gov, the official NIH registry, and is overseen by an Institutional Review Board (IRB). Before joining you receive an informed consent document detailing procedures, risks and compensation. Participation is voluntary and you can withdraw at any time.

Q: How do I join a study in Sioux Falls, SD?

Pick a study that matches your profile, contact the research site (or apply through the study links on this page), pass a phone pre-screen, then attend an in-person screening visit. If you qualify, you review and sign the informed consent and the study begins. The process typically takes 1-3 weeks.

Q: How often do new paid studies open in Sioux Falls?

Constantly — trials open and close enrollment every week. This page is refreshed weekly from the NIH registry. Join the email alert to be notified when a new study opens within 30 miles of Sioux Falls.

Q: Can I be in more than one clinical trial at a time?

Generally no — most studies exclude participants currently enrolled in another trial, and paid Phase 1 studies enforce a washout period (often 30 days or more) between studies. Frequent healthy volunteers in Sioux Falls typically complete one or two studies per year.

Studies commonly pay $75 to $4,500 per completed study

264 clinical trials are currently recruiting participants within 30 miles of Sioux Falls. Listings below come straight from the official NIH registry, alongside the area's top-rated research centers with real Google reviews.

264studies recruiting

4+research centers nearby

2condition categories

Live from the NIH registry

Studies recruiting near Sioux Falls right now

Top 25 of 264 recruiting studies, sorted by proximity — each links to its official registry page

Lung-MAP: A Master Screening Protocol for Previously-Treated Non-Small Cell Lung Cancer

Previously Treated Non-Small Cell Lung Cancer Phase 2, Phase 3 Interventional 10,000 participants sought

Sanford Cancer Center Oncology Clinic — Sioux Falls, South Dakota (0.3 mi) · Sponsor: SWOG Cancer Research Network

See eligibility & contact on ClinicalTrials.gov (NCT03851445)

KEYMAKER-U01 Substudy 01A: Efficacy and Safety Study of Pembrolizumab (MK-3475) With or Without Chemotherapy When Used With Investigational Agents in Treatment-naïve Participants With Stage IV Non-small Cell Lung Cancer (NSCLC) (MK-3475-01A/KEYMAKER-U01A)

Carcinoma, Non-Small-Cell Lung Phase 1, Phase 2 Interventional 450 participants sought

Sanford Cancer Center ( Site 0038) — Sioux Falls, South Dakota (0.3 mi) · Sponsor: Merck Sharp & Dohme LLC

See eligibility & contact on ClinicalTrials.gov (NCT04165070)

A Study Testing the Combination of Dasatinib or Imatinib to Chemotherapy Treatment With Blinatumomab for Children, Adolescents, and Young Adults With Philadelphia Chromosome Positive (Ph+) or ABL-Class Philadelphia Chromosome-Like (Ph-Like) B-cell Acute Lymphoblastic Leukemia (B-ALL)

B Acute Lymphoblastic Leukemia Phase 2 Interventional 222 participants sought

Sanford USD Medical Center - Sioux Falls — Sioux Falls, South Dakota (0.3 mi) · Sponsor: National Cancer Institute (NCI)

See eligibility & contact on ClinicalTrials.gov (NCT06124157)

Palbociclib and Cetuximab Versus Cetuximab Monotherapy for Patients With CDKN2A-altered, HPV-unrelated Head and Neck Squamous Cell Carcinoma Who Experienced Disease Progression on a PD-1/L1 Inhibitor

HPV-unrelated Head and Neck Squamous Cell Carcinoma Phase 3 Interventional 81 participants sought

Sanford Medical Center — Sioux Falls, South Dakota (0.3 mi) · Sponsor: Washington University School of Medicine

See eligibility & contact on ClinicalTrials.gov (NCT04966481)

DESTINY-Endometrial01: A Phase III Study of Trastuzumab Deruxtecan Plus Rilvegostomig or Pembrolizumab as First-Line Treatment of HER2-Expressing (IHC 3+/2+), Mismatch Repair Proficient (pMMR) Endometrial Cancer

Endometrial Cancer Phase 3 Interventional 600 participants sought

Research Site — Sioux Falls, South Dakota (0.3 mi) · Sponsor: AstraZeneca

See eligibility & contact on ClinicalTrials.gov (NCT06989112)

A Study of Vepugratinib (LY3866288) in Participants With Cancer in the Urinary Tract

Carcinoma, Transitional Cell, Urinary Bladder Neoplasms Phase 3 Interventional 450 participants sought

Avera Cancer Institute- Research — Sioux Falls, South Dakota (0.3 mi) · Sponsor: Eli Lilly and Company

See eligibility & contact on ClinicalTrials.gov (NCT07218380)

Comparing Combinations of Drugs to Treat Newly Diagnosed Multiple Myeloma (NDMM) When a Stem Cell Transplant is Not a Medically Suitable Treatment

Plasma Cell Myeloma Phase 3 Interventional 510 participants sought

Sanford Cancer Center Oncology Clinic — Sioux Falls, South Dakota (0.3 mi) · Sponsor: SWOG Cancer Research Network

See eligibility & contact on ClinicalTrials.gov (NCT05561387)

Study of Trastuzumab Deruxtecan Versus Standard of Care Chemotherapy for HER2-Expressing (IHC 3+/2+) Endometrial Cancer

Endometrial Cancer Phase 3 Interventional 710 participants sought

Avera Medical Group Gynecologic Oncology Sioux Falls — Sioux Falls, South Dakota (0.3 mi) · Sponsor: Daiichi Sankyo

See eligibility & contact on ClinicalTrials.gov (NCT07022483)

Testing Different Dosing Schedules of the Anti-cancer Drug, Lutetium 177Lu PSMA RLT and Its Effect on Patients With Advanced Prostate Cancer, RECIPROCAL Trial

Metastatic Castration-Resistant Prostate Carcinoma, Metastatic Prostate Adenocarcinoma Phase 3 Interventional 1,524 participants sought

Sanford Cancer Center Oncology Clinic — Sioux Falls, South Dakota (0.3 mi) · Sponsor: Alliance for Clinical Trials in Oncology

See eligibility & contact on ClinicalTrials.gov (NCT07200830)

A Study of Sigvotatug Vedotin in Advanced Solid Tumors

Carcinoma, Non-Small Cell Lung, Squamous Cell Carcinoma of Head and Neck Phase 1 Interventional 1,006 participants sought

Sanford Cancer Center — Sioux Falls, South Dakota (0.3 mi) · Sponsor: Seagen, a wholly owned subsidiary of Pfizer

See eligibility & contact on ClinicalTrials.gov (NCT04389632)

A Study to Compare Standard Therapy to Treat Hodgkin Lymphoma to the Use of Two Drugs, Brentuximab Vedotin and Nivolumab

Lugano Classification Limited Stage Hodgkin Lymphoma AJCC v8 Phase 3 Interventional 1,875 participants sought

Sanford USD Medical Center - Sioux Falls — Sioux Falls, South Dakota (0.3 mi) · Sponsor: National Cancer Institute (NCI)

See eligibility & contact on ClinicalTrials.gov (NCT05675410)

Evaluating the Efficacy and Safety of PT027 Compared With PT007 Administered As Needed in Participants 12 to < 18 Years of Age With Asthma

Asthma Phase 3 Interventional 440 participants sought

Research Site — Sioux Falls, South Dakota (0.3 mi) · Sponsor: AstraZeneca

See eligibility & contact on ClinicalTrials.gov (NCT06307665)

Sacituzumab Tirumotecan (MK-2870) Plus Pembrolizumab Versus TPC in TNBC Who Did Not Achieve pCR (MK-2870-012)

Triple-Negative Breast Cancer Phase 3 Interventional 1,530 participants sought

Sanford Cancer Center ( Site 0059) — Sioux Falls, South Dakota (0.3 mi) · Sponsor: Merck Sharp & Dohme LLC

See eligibility & contact on ClinicalTrials.gov (NCT06393374)

MYELOMATCH: A Screening Study to Assign People With Myeloid Cancer to a Treatment Study or Standard of Care Treatment Within myeloMATCH (MyeloMATCH Screening Trial)

Acute Myeloid Leukemia, Acute Myeloid Leukemia Arising From Previous Myelodysplastic/Myeloproliferative Neoplasm Phase 2 Interventional 2,000 participants sought

Sanford Cancer Center Oncology Clinic — Sioux Falls, South Dakota (0.3 mi) · Sponsor: National Cancer Institute (NCI)

See eligibility & contact on ClinicalTrials.gov (NCT05564390)

Radiation Therapy With or Without Cisplatin in Treating Patients With Stage III-IVA Squamous Cell Carcinoma of the Head and Neck Who Have Undergone Surgery

Head and Neck Squamous Cell Carcinoma, Hypopharyngeal Squamous Cell Carcinoma Phase 2 Interventional 189 participants sought

Sanford Cancer Center Oncology Clinic — Sioux Falls, South Dakota (0.3 mi) · Sponsor: ECOG-ACRIN Cancer Research Group

See eligibility & contact on ClinicalTrials.gov (NCT02734537)

A Study of the Drug Selinexor With Radiation Therapy in Patients With Newly-Diagnosed Diffuse Intrinsic Pontine (DIPG) Glioma and High-Grade Glioma (HGG)

Malignant Glioma Phase 1, Phase 2 Interventional 132 participants sought

Sanford USD Medical Center - Sioux Falls — Sioux Falls, South Dakota (0.3 mi) · Sponsor: National Cancer Institute (NCI)

See eligibility & contact on ClinicalTrials.gov (NCT05099003)

A Study of Azenosertib (ZN-c3) in Subjects With Platinum-Resistant High-Grade Serous Ovarian, Fallopian Tube or Primary Peritoneal Cancer

High-Grade Serous Ovarian, Fallopian Tube or Primary Peritoneal Cancer Phase 2 Interventional 310 participants sought

Site 0132 - Avera Cancer Institute — Sioux Falls, South Dakota (0.3 mi) · Sponsor: K-Group, Beta, Inc., a wholly owned subsidiary of Zentalis Pharmaceuticals, Inc

See eligibility & contact on ClinicalTrials.gov (NCT05128825)

Pounce™ Thrombectomy System Retrospective Registry

Peripheral Arterial Disease, Acute Limb Ischemia N/A Observational 500 participants sought

North Central Heart — Sioux Falls, South Dakota (0.3 mi) · Sponsor: SurModics, Inc.

See eligibility & contact on ClinicalTrials.gov (NCT05868161)

A Study to Evaluate Vimseltinib in Adults With Active Chronic Graft-Versus-Host Disease (cGVHD)

Chronic Graft-Versus-Host Disease (cGVHD) Phase 2 Interventional 48 participants sought

Avera Cancer Institute — Sioux Falls, South Dakota (0.3 mi) · Sponsor: Deciphera Pharmaceuticals, LLC

See eligibility & contact on ClinicalTrials.gov (NCT06619561)

A Study of BGB-B455 in Adults With Advanced or Metastatic Solid Tumors

Advanced Solid Tumor, Metastatic Solid Tumor Phase 1 Interventional 90 participants sought

Avera Cancer Institute — Sioux Falls, South Dakota (0.3 mi) · Sponsor: BeOne Medicines

See eligibility & contact on ClinicalTrials.gov (NCT06803680)

Connect for Cancer Prevention Study (Connect)

Cancer, General Research Use N/A Observational 200,000 participants sought

Sanford Health — Sioux Falls, South Dakota (0.3 mi) · Sponsor: National Cancer Institute (NCI)

See eligibility & contact on ClinicalTrials.gov (NCT04609072)

Dinutuximab With Chemotherapy, Surgery and Stem Cell Transplantation for the Treatment of Children With Newly Diagnosed High Risk Neuroblastoma

Ganglioneuroblastoma, Nodular, Neuroblastoma Phase 3 Interventional 478 participants sought

Sanford USD Medical Center - Sioux Falls — Sioux Falls, South Dakota (0.3 mi) · Sponsor: National Cancer Institute (NCI)

See eligibility & contact on ClinicalTrials.gov (NCT06172296)

Real-World Data Collection of the GORE® VIABAHN® VBX Balloon Expandable Endoprosthesis When Used in Covered Endovascular Reconstruction of the Aortic Bifurcation (CERAB) to Treat Aortoiliac Occlusive Disease

Aortoiliac Occlusive Disease N/A Observational 158 participants sought

Sanford Clinical Vascular Associates — Sioux Falls, South Dakota (0.3 mi) · Sponsor: W.L.Gore & Associates

See eligibility & contact on ClinicalTrials.gov (NCT06872905)

Ambulatory Long Length URodynamics Evaluation

Urology, Urinary Bladder, Overactive N/A Interventional 101 participants sought

Sanford Health — Sioux Falls, South Dakota (0.3 mi) · Sponsor: Bright Uro

See eligibility & contact on ClinicalTrials.gov (NCT07425015)

Testing the Addition of High Dose, Targeted Radiation to the Usual Treatment for Locally-Advanced Inoperable Non-Small Cell Lung Cancer

Locally Advanced Lung Non-Small Cell Carcinoma, Stage IIB Lung Cancer AJCC v8 Phase 3 Interventional 474 participants sought

Sanford Cancer Center Oncology Clinic — Sioux Falls, South Dakota (0.3 mi) · Sponsor: NRG Oncology

See eligibility & contact on ClinicalTrials.gov (NCT05624996)

Actively enrolling

Studies you may be able to join near Sioux Falls

These studies are recruiting through partner research networks. We may be paid a referral fee if you complete their screening form — this never changes what you pay (nothing) or the compensation the study offers you.

Research study for alcohol-related liver damage

Enrolling US adults aged 18 to 70 with alcohol-induced liver damage and a history of heavy drinking. Not open to people with a recent stroke, heart attack, dialysis, or who take blood thinners.

Screening is free and takes a few minutes. Eligibility and any compensation are confirmed by the study team, not by this site.

Check your eligibility

Research study for bladder problems after spinal cord injury

This study is enrolling US adults aged 18 to 75 living with chronic involuntary bladder leakage caused by a spinal cord injury, for research including investigational gene therapy approaches. The study team confirms eligibility and any compensation before enrollment.

Screening is free and takes a few minutes. Eligibility and any compensation are confirmed by the study team, not by this site.

Check your eligibility

Google-rated

Top-rated research centers in Sioux Falls

Dedicated clinical research sites near you — with their real Google ratings, reviews and contact details

Avera Research Institute — Sioux Falls

6001 S Sharon Ave, Sioux Falls, SD 57108

(605) 504-3154

Website

Sanford Research

★ 5.0

2301 East 60th St N, Sioux Falls, SD 57104

(605) 312-6300

Website

Sanford Imagenetics

★ 4.1

1321 W 22nd St, Sioux Falls, SD 57105

(605) 404-4000

Website

Circle Clinical Research

(605) 215-1159

Website

Clinical trials in Sioux Falls: what's recruiting

The Sioux Falls area currently has 264 studies open to new participants, according to the ClinicalTrials.gov registry maintained by the U.S. National Institutes of Health. Among the studies closest to Sioux Falls, the most active research areas are:

Cancer & Oncology20 studies
Lungs & Breathing1 studies

Every listing shows the study phase, the recruiting site and its distance from Sioux Falls, and links to the official registry page where eligibility criteria and study contacts are published. Compensation is set by each sponsor: industry surveys report typical payments of $75 to $4,500 per completed study, with short observational studies at the low end and multi-visit or overnight Phase 1 studies at the high end.

How to enroll in a paid study in Sioux Falls

Start with a study whose condition matches your profile — or a healthy-volunteer study if you have no diagnosis. Contact the research site through the registry page, complete a short phone screen, then attend an in-person screening visit. If you qualify, the study team walks you through the informed consent document, which details every procedure, risk and payment before you commit. You can withdraw at any point, and enrollment is always free.

Sioux Falls participants can also register with the dedicated research centers listed above — many maintain volunteer databases and call when a matching study opens — or sign up for our email alert below to hear when a new study starts recruiting within 30 miles of your ZIP code.

Frequently asked questions

Do I need to be sick to join a clinical trial in Sioux Falls?

No. Many studies recruit healthy volunteers, especially early-phase studies run at dedicated research centers. Others need participants diagnosed with a specific condition. Every trial lists its eligibility criteria — age range, condition, medications — and the study team screens you before enrollment.

Are clinical trials in Sioux Falls safe?

Every trial on this page is registered on ClinicalTrials.gov, the official NIH registry, and is overseen by an Institutional Review Board (IRB). Before joining you receive an informed consent document detailing procedures, risks and compensation. Participation is voluntary and you can withdraw at any time.

How do I join a study in Sioux Falls, SD?

Pick a study that matches your profile, contact the research site (or apply through the study links on this page), pass a phone pre-screen, then attend an in-person screening visit. If you qualify, you review and sign the informed consent and the study begins. The process typically takes 1-3 weeks.

How often do new paid studies open in Sioux Falls?

Constantly — trials open and close enrollment every week. This page is refreshed weekly from the NIH registry. Join the email alert to be notified when a new study opens within 30 miles of Sioux Falls.

Can I be in more than one clinical trial at a time?

Generally no — most studies exclude participants currently enrolled in another trial, and paid Phase 1 studies enforce a washout period (often 30 days or more) between studies. Frequent healthy volunteers in Sioux Falls typically complete one or two studies per year.

Paid clinical trials near Sioux Falls

Other metros within reach

Omaha, NE595 Lincoln, NE162 Fargo, ND201 Des Moines, IA221 Minneapolis, MN1,090 St. Paul, MN1,092 Topeka, KS109 Kansas City, KS1,035

New paid studies open every week

Get an email when a new clinical trial starts recruiting within 30 miles of your ZIP code. No spam — only real studies from the NIH registry.

Get free trial alerts